Acquisitions - Acquisition Purchase Price (Details) - BioDiscovery $ / shares in Units, shares in Thousands, $ in Thousands |
1 Months Ended |
|---|---|
|
Oct. 31, 2021
USD ($)
$ / shares
shares
| |
| Business Acquisition [Line Items] | |
| Cash | $ 52,291 |
| Estimated fair value of milestone consideration | 9,000 |
| Return of cash to buyer from escrow | $ (694) |
| Shares of common stock issued as consideration (in shares) | shares | 2,723 |
| Stock price per share on Effective Date (in dollars per share) | $ / shares | $ 5.20 |
| Value of estimated common stock consideration | $ 14,159 |
| Total purchase price | $ 74,756 |
| X | ||||||||||
- Definition Business Combination, Estimated Return of Cash to Buyer from Escrow No definition available.
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|